No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor. (2021)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-020-80464-1
PubMed Identifier: 33432067
Publication URI: http://europepmc.org/abstract/MED/33432067
Type: Journal Article/Review
Volume: 11
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322